Home/Filings/4/0000950170-24-077029
4//SEC Filing

HIGH SUSANNA GATTI 4

Accession 0000950170-24-077029

CIK 0001818794other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 8:41 PM ET

Size

13.9 KB

Accession

0000950170-24-077029

Insider Transaction Report

Form 4
Period: 2024-06-21
HIGH SUSANNA GATTI
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2024-06-21$35.01/sh29,787$1,042,843148,792 total
  • Exercise/Conversion

    Stock option (right to buy)

    2024-06-2410,16360,536 total
    Exercise: $5.54Exp: 2030-07-30Common Stock (10,163 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-24$5.54/sh+10,163$56,303158,955 total
  • Sale

    Common Stock

    2024-06-24$35.33/sh10,163$359,059148,792 total
  • Exercise/Conversion

    Stock option (right to buy)

    2024-06-2129,78770,699 total
    Exercise: $5.54Exp: 2030-07-30Common Stock (29,787 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-21$5.54/sh+29,787$165,020178,579 total
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $35.00 to $35.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $35.00 to $35.60, inclusive.
  • [F4]Includes 134,629 unvested RSUs.
  • [F5]The option was granted on July 31, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on July 31, 2021 and the remaining shares vesting in equal quarterly installments thereafter.

Documents

1 file

Issuer

Dyne Therapeutics, Inc.

CIK 0001818794

Entity typeother

Related Parties

1
  • filerCIK 0001691005

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 8:41 PM ET
Size
13.9 KB